Anthrax as a Biological Weapon: Medical and Public Health Management
Clicks: 295
ID: 114185
1999
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
295 views
31 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #73 of 149 articles by views in JAMA
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 149 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Objective To develop consensus-based recommendations for measures to be taken by medical and public health professionals following the use of anthrax as a biological weapon against a civilian population. Participants The working group included 21 representatives from staff of major academic medical centers and research, government, military, public health, and...
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (49 words).
Try re-searching for a better abstract.
| Reference Key |
inglesby1999jamaanthrax
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Thomas V. Inglesby;Donald A. Henderson;John G. Bartlett;Michael S. Ascher;Edward Eitzen;Arthur M. Friedlander;Jerome Hauer;Joseph McDade;Michael T. Osterholm;Tara O'Toole;Gerald Parker;Trish M. Perl;Philip K. Russell;Kevin Tonat;for the Working Group on Civilian Biodefense; |
| Journal | JAMA |
| Year | 1999 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.